Vaccines Based on Immunotherapies Being Tested in Phase 2 Trials in Brain Cancer – Immuno-Oncology News
|
Vaccines Based on Immunotherapies Being Tested in Phase 2 Trials in Brain Cancer
Immuno-Oncology News Immunomic Therapeutics has entered an exclusive licensing agreement with Annias Immunotherapeutics for the rights to use Annia's intellectual property regarding an immunotherapy based on antigens of cytomegalovirus (CMV). Both companies are … |
